ArticleJournal of epidemiology and global health2025
Quantifying Suicide Risk in Prostate Cancer: A SEER-Based Predictive Model.
Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProstate cancer patients have a significantly higher risk of suicide compared to the general population. This study aimed to develop a nomogram for identifying high-risk patients and providing empirical evidence to guide effective intervention strategies.
methodsWe analyzed data from 176,730 prostate cancer patients diagnosed between 2004 and 2021, sourced from the Surveillance, Epidemiology, and End Results (SEER) database. Patients were randomly allocated to training (n = 123,711) and validation (n = 53,019) cohorts in a 7:3 ratio. Feature selection was conducted using the Least Absolute Shrinkage and Selection Operator (LASSO), followed by model construction with Cox proportional hazards regression. The results were visualized using nomogram. Model performance was evaluated with time-dependent receiver operating characteristic (ROC) curves, concordance index (C-index), and internal validation.
resultsMultivariate analysis identified seven independent predictors of suicide. The nomogram demonstrated favorable discriminative capability in both cohorts, with C-index of 0.746 and 0.703 for the training and bootstrapped validation cohorts. Time-dependent ROC analysis indicated strong accuracy in predicting suicide risk. Calibration plots displayed high concordance between predicted probabilities and actual outcomes, Kaplan-Meier analysis confirmed the model's significant discriminative ability among risk groups. LIMITATIONS: This retrospective study, based on SEER data, lacks detailed clinical and mental health information. Additionally, potential coding errors and reporting biases may affect the accuracy of the results.
conclusionWe developed a applicable nomogram for the individualized quantification of suicide risk in prostate cancer patients. This model provides clinicians with a robust tool for identifying high-risk patients and implementing timely interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.